Early predictive factors of molecular relapse in chronic phase-chronic myeloid leukemia (CP-CML) patients after tyrosine kinase inhibitor (TKI) discontinuation

Laganà A et al. Leuk Lymphoma, November 2025 (epub ahead of print)

• Share
• Tweet
• Share
• Share